Weight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart Disease

The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers